PU 2049 is a Melatonin ( HY-B0075 ) derivative. PU 2049 exhibits greater efficacy than Melatonin in reducing skin scaling and erythematous papular lesions. PU 2049 can be used in the research of psoriasis.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Drug Derivative
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye